FEDERAL AGENCY:

CENTERS FOR DISEASE CONTROL AND PREVENTION, DEPARTMENT OF HEALTH AND HUMAN SERVICES

AUTHORIZATION:

Public Health Service Act, Section 317(a)317E, 42 U.S.C. 247b-b(a), as amended; Health Services and Centers Amendments of 1978, Public Law 95-626; Omnibus Budget Reconciliation Act of 1981, as amended, Public Law 97-35; Preventive Health Amendments of 1984, Public Law 98-555; Public Health Service Act of 1987, as amended, Public Law 100-177; TB Prevention Amendments Act of 1990, as amended, Public Law 101-368.

OBJECTIVES:

To assist State and local health agencies in carrying out tuberculosis control activities designed to prevent transmission of infection and disease. Financial assistance is provided to TB programs to ensure that the program needs for the core TB prevention and control activities are met: finding all cases of active tuberculosis and ensuring completion of therapy; finding and screening persons who have had contact with TB patients, evaluating them for TB infection and disease, and ensuring completion of appropriate treatment, and conducting TB surveillance and TB public health laboratory activities that are essential to addressing these priorities. Each of these core activities (completion of therapy, contact investigation, TB surveillance, and TB laboratory activities) is essential to effective TB prevention and control, and they are mutually reinforcing. Thus, they constitute a "package" of core activities. These are the highest priority TB prevention and control activities and should be carried out by all State and local TB prevention and control programs.

TYPES OF ASSISTANCE:

Project Grants. Place Cursor Here for Definition

USES AND USE RESTRICTIONS:

Project funds may be used to support both local personnel and individuals in direct assistance (i.e., "in lieu of cash") positions under Section 317 of the Public Health Service Act and to purchase equipment, supplies and services directly related to project activities, particularly directly observed therapy, patient outreach, morbidity surveillance, outreach and program assessment. Project funds may not be used to supplant State or local funds available for tuberculosis control, or to support construction costs or inpatient care.

ELIGIBILITY REQUIREMENTS:

Applicant Eligibility:   Under Section 317 of the Public Health Service Act, official public health agencies or their bona fide agents of State and local governments, including the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, the Northern Mariana Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, the Republic of Palau, and American Samoa.

Beneficiary Eligibility:   Official public health agencies of State and local governments, including the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, the Northern Mariana Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, the Republic of Palau, and American Samoa.

Credentials/Documentation:   Applicants should document the need for assistance, state the objectives of the project, outline the method of operations, describe the evaluation procedures, and provide a budget with justification of funds requested. Costs will be determined in accordance with OMB Circular No. A-87 for State and local governments.

Pre-application Coordination:   Preapplication coordination is not required. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review.

Application Procedure:   Information on the submission of applications may be obtained from the Grants Management Officer, Grants Management Branch, Procurement and Grants Office, Centers for Disease Control and Prevention. The standard application forms, as furnished by PHS and required by 45 CFR 92 for State and local governments, must be used for this program. This program is subject to the requirements described in 45 CFR 92.

Award Procedure:   After officials review and approve applications, a Notice of Award is prepared and processed, and appropriate notification is made to the public.

Deadlines:   Contact Headquarters Office for application deadline.

Range of Approval/Disapproval Time:   From 3 to 6 months.

Appeals:   Not applicable.

Renewals:   Information on the submission of applications may be obtained from the Grants Management Officer, Grants Management Branch, Procurement and Grants Office, Centers for Disease Control and Prevention. The standard application forms, as furnished by PHS and required by 45 CFR 92 for State and local governments, must be used for this program. This program is subject to the requirements described in 45 CFR 92.

ASSISTANCE CONSIDERATIONS:

Formula and Matching Requirements:   This program has no statutory formula or matching requirements. Although there are no matching requirements, applicants must assume part of the project costs and fiscal information must be provided in the narrative portion of the application pursuant to provisions of Section 317(b)(2)317E.

Length and Time Phasing of Assistance:   Project Period: From 1 to 5 years. Budget Period: 1 year.

POST ASSISTANCE REQUIREMENTS:

Reports:   Quarterly or semiannual narrative and performance statistical reports are required. Financial status reports are required no later than 90 days after the end of each budget period. Final financial status and progress reports are required 90 days after the end of a project period.

Audits:   In accordance with the provisions of OMB Circular No. A- 133 (Revised, June 24, 1997), "Audits of States, Local Governments, and Nonprofit Organizations," nonfederal entities that expend financial assistance of $300,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $300,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal officials.

Records:   Financial records, supporting documents, statistical records, and all other records pertinent to the project shall be retained for a minimum of 3 years, or until completion and resolution of any audit in process or pending resolution. In all cases, records must be retained until resolution of any audit questions. Property records must be retained in accordance with PHS Grants Policy Statement requirements.

FINANCIAL INFORMATION:

Account Identification:   75-0943-0-1-550.

Obligations:   (Grants and Cooperative Agreements): FY 01 $101,871,042; FY 02 est $103,465,877; and FY 03 est $103,500,000.

Range and Average of Financial Assistance:  
$86,938 to $9,9,317,764 with an average of $1,454,714.

Support was provided to 68 cooperative agreements in fiscal year 2001. It is estimated that support will continue for 68 cooperative agreements in fiscal year 2002 and fiscal year 2003, with continued special emphasis on the Nation's inner cities where much of the tuberculosis morbidity occurs.

REGULATIONS, GUIDELINES, AND LITERATURE:

Subpart A of 42 CFR 51b is applicable, including all regulations incorporated by reference under Section 51b.105. PHS Grants Policy Statement, DHHS Publication No. (OASH) 94-50,000, (Rev.) April 1, 1994, is available.

INFORMATION CONTACTS:

Regional or Local Office:   Not applicable.

Headquarters Office:  
Terry Chorba 1600 Clifton Road, MS E-10, Atlanta, Georgia 30333 Email: tlc2@cdc.gov Phone: 404-639-0909 Fax: 404-639-8958

Web Site Address:  
https://www.cdc.gov/

EXAMPLES OF FUNDED PROJECTS:

Cooperative agreements are provided to health departments to intensify tuberculosis prevention and control activities, primarily through the use of outreach workers.

CRITERIA FOR SELECTING PROPOSALS:

Applications will be evaluated in 2000 on the 1999 data including the total number of cases reported, the number of bacteriologically confirmed cases reported, the bacteriologically substantiated rate of disease, the number of tuberculosis cases among racial and ethnic minorities, significant tuberculosis problems among the homeless, cumulative number of TB/AIDS cases, and significant increases in tuberculosis morbidity. The number of tuberculosis cases under current supervision which have organisms resistant to one or more anti-tuberculosis drugs will also be considered in evaluating and prioritizing projects for funding. In addition, the overall potential effectiveness of the applicant's plan of operation in meeting the objectives of proposed projects will be considered in evaluating and prioritizing projects.